Overview
MISSION: To develop a comprehensive policy research agenda, foster translating this research into practice, and investigate relevant economic models.
Year End Report, April 2010
Current Activities
1) A peer reviewed journal article on recommendations and outcomes from the Expert Symposium, "Economics of Cardiovascular Disease: Defining the Research Agenda" (Symposium information and slides can be found below).
2) Review of the literature on the health economics/cost effectiveness of prevention and treatment of CVD in children.
Member Roster
Chair: Alexander White, JD, MPH, Cardiovascular Health Council Delegate North Carolina
Vice-chair: Yuling Hong, Centers for Disease Control and Prevention
Meredith Kilgore, RN, PhD, University of Alabama
Diane Orenstein, PhD, Centers for Disease Control and Prevention
Guijing Wang, PhD, Centers for Disease Control and Prevention
Armineh Zohrabian, PhD, Centers for Disease Control and Prevention
Staff: Faith Berrier
EXPERT SYMPOSIUM “ECONOMICS OF CARDIOVASCULAR DISEASE: DEFINING THE RESEARCH AGENDA”
May 14, 2009
Washington, DC
Embassy Suites—Washington Convention Center
The National Forum for Heart Disease and Stroke Prevention hosted the EXPERT SYMPOSIUM “ECONOMICS OF CARDIOVASCULAR DISEASE: DEFINING THE RESEARCH AGENDA” on May 14, 2009, in Washington, DC at the Embassy Suites Hotel Washington Convention Center. The purpose of the Symposium was to evaluate the economic and public health implications of heart disease and stroke prevention, and identify key areas for future research. The results of the Symposium will inform public health organizations, policy makers and research institutions about cost-effective strategies and research needs for the prevention of heart disease and stroke at the population level.
Thirty-five experts in heart disease, stroke, health policy, public health, health economics and representatives from business participated in the Symposium. A major goal for convening these experts was to create a set of prioritized recommendations, including identifying gaps in current research, that can be used to develop an economic and policy research agenda for heart disease and stroke prevention. Key questions answered by the Symposium were:
1. What is currently known about health economic research related to heart disease and stroke prevention?
2. What are the health economic research needs and opportunities for heart disease and stroke prevention?
3. What are policy implications pertaining to the economics of heart disease and stroke prevention from a public health standpoint?
The results of the Symposium will be compiled into a summary document or journal supplement and, if appropriate, a manuscript on the expert recommendations will be published. To view the slides for each presentation made at the Symposium, please click on the presentation title below:
Welcome and Overview Mark Schoeberl, Chair National Forum
Dr. Keith Ferdinand, Chair, Policy Research Implementation Group
Opening Presentation: Economics of CVD Prevention: The Critical Question
Dr. Darwin Labarthe, Director-Division of Heart Disease
and Stroke Prevention, CDC
Bridging the Gap Between Public Health, Academia, the Business World and the Health Care Policy World to Build the Case for Prevention of Heart Disease and Stroke
Dr. Ron Goetzel, Emory University
Health Disparities in the US with a Focus on Cardiovascular Diseases
Dr. Ali Mokdad, University of Washington, School of Public Health
Cardiovascular Consumption Groups in a Medicare Fee for Service Population: Concentration of Medical Expenditures 2000-2006 Dr. Gary Puckrein, Executive Director-National Minority
Health Foundation
LUNCHEON SPEAKER: CBO Scoring 101—The Value of Prevention Jennifer Bowman, Director-Avalere Health
Survey: Knowledge Needs in Health Economics of Heart Disease and Stroke Prevention—Progress Report Dr. Eric Finkelstein, RTI International
Economic Evaluation of Public Policies on CVD Risk Factors
Dr. Terry Pechacek, Associate Director for Science, Office of Smoking and Health, CDC
Simulating and Evaluating Local Interventions to Improve Cardiovascular Health Dr. Justin Trogdon, RTI International
SETTING THE AGENDA: Creating a Prioritized List of
Research Priorities
Dr. Meredith Kilgore, University of Alabama at Birmingham